We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

3 hedge funds and large institutions have $2.16M invested in SpringWorks Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 217 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 222 → 3 (-219)

99.54% less ownership

Funds ownership: 99.59% → 0.05% (-100%)

100% less capital invested

Capital invested by funds: $3.53B → $2.16M (-$3.52B)

100% less funds holding in top 10

Funds holding in top 10: 18 → 0 (-18)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 217

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-219
Holders Change %
-98.65%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
217
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$341M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$335M
3
GCL
Glazer Capital LLC
New York
-$193M
4
Fidelity International
Fidelity International
Bermuda
-$142M
5
State Street
State Street
Massachusetts
-$141M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
Pentwater Capital Management
Florida
– -$47M -1,000,000 Closed
WA
27
Whitebox Advisors
Minnesota
– -$37.4M -795,191 Closed
TC
28
Trium Capital
United Kingdom
– -$37M -787,459 Closed
KC
29
Kryger Capital
United Kingdom
– -$36M -765,522 Closed
Renaissance Technologies
30
Renaissance Technologies
New York
– -$35.7M -760,600 Closed
Balyasny Asset Management
31
Balyasny Asset Management
Illinois
– -$33.1M -705,364 Closed
WIC
32
Water Island Capital
New York
– -$33.1M -703,525 Closed
HM
33
Harvest Management
New York
– -$32.3M -687,500 Closed
GF
34
Gabelli Funds
New York
– -$32.1M -683,201 Closed
OBAM
35
ODDO BHF Asset Management
France
– -$30.3M -645,000 Closed
Northern Trust
36
Northern Trust
Illinois
– -$30.3M -644,631 Closed
ACH
37
ArrowMark Colorado Holdings
Colorado
– -$29M -617,024 Closed
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
– -$27.5M -585,122 Closed
SGCM
39
Sand Grove Capital Management
United Kingdom
– -$26.9M -572,392 Closed
Hudson Bay Capital Management
40
Hudson Bay Capital Management
Connecticut
– -$25.7M -547,010 Closed
Millennium Management
41
Millennium Management
New York
– -$25.6M -544,856 Closed
SFM
42
Soros Fund Management
New York
– -$23.6M -501,989 Closed
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
– -$22.8M -484,874 Closed
WP
44
Woodline Partners
California
– -$20.5M -437,000 Closed
Charles Schwab
45
Charles Schwab
California
– -$20.3M -432,624 Closed
UBS Group
46
UBS Group
Switzerland
– -$18.5M -392,884 Closed
Janus Henderson Group
47
Janus Henderson Group
United Kingdom
– -$18M -383,701 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
48
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$16.7M -355,000 Closed
PSAMP
49
P. Schoenfeld Asset Management (PSAM)
New York
– -$16.5M -351,400 Closed
GCIA
50
Gabelli & Co Investment Advisers
New York
– -$15.2M -324,350 Closed
1
2
3 4 5

SWTX Hedge Fund Activity: Q3 2025 in Review

3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2025, worth a combined $2.16M — down 100% from $3.53B a quarter earlier.

Sellers outnumbered buyers: 217 funds closed out of SWTX and 0 opened new positions — a net loss of 217 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $341M sold.

  • 3 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2025, down from 222 in Q2 2025.
  • Funds reported $2.16M of SpringWorks Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new SpringWorks Therapeutics positions in Q3 2025 and 217 closed out, a net change of -217 holders.
  • The largest SpringWorks Therapeutics seller in Q3 2025 was BlackRock, an estimated $341M sold.

Based on aggregated 13F filings for Q3 2025.